Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

E-ISSN： 2212-3903|7|4|281-289

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.7, Iss.4, 2012-12, pp. : 281-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

By Robak Tadeusz Robak Ewa

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 13-25

Adis International

Access to resources Recommend Favorite

Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia

By Robak Tadeusz

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 9-22

Adis International

Access to resources Recommend Favorite

Pilot clinical trial of an anti-TNF monoclonal antibody for the treatment of septic shock

By BOILLOT A CAPELLIER G RACADOT E WIJDENES J HERVE P BARALE F

Clinical Intensive Care, Vol. 6, Iss. 2, 1995-04 ,pp. : 52-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV‐infected patient on antiretroviral therapy: a case report and review of the literature

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 453-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐CD20 inhibits T cell‐mediated pathology and microgliosis in the rat brain

Annals Of Clinical And Translational Neurology, Vol. 1, Iss. 9, 2014-09 ,pp. : 659-669

John Wiley & Sons Inc

Access to resources Recommend Favorite